Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. (Q42830363)
Jump to navigation
Jump to search
scientific article published on 8 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. |
scientific article published on 8 March 2007 |
Statements
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor (English)
Yujia Dai
Kresna Hartandi
Zhiqin Ji
Asma A Ahmed
Daniel H Albert
Joy L Bauch
Jennifer J Bouska
Peter F Bousquet
George A Cunha
Keith B Glaser
Christopher M Harris
Dean Hickman
Jun Guo
Junling Li
Patrick A Marcotte
Kennan C Marsh
Maria D Moskey
Ruth L Martin
Amanda M Olson
Donald J Osterling
Lori J Pease
Niru B Soni
Vincent S Stoll
Paul Tapang
David R Reuter
Steven K Davidsen
Michael R Michaelides
8 March 2007